Yoshiaki Nakamura Selected Research

Yoshiaki Nakamura Research Topics

Disease

41	Neoplasms (Cancer) 10/2022 - 03/2011
21	Stomach Neoplasms (Stomach Cancer) 06/2022 - 01/2018
19	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 11/2018
11	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2003
8	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2015
5	Microsatellite Instability 01/2022 - 11/2018
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2021 - 01/2020
4	Disease Progression 01/2022 - 01/2003
2	Fever (Fevers) 12/2021 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 07/2021 - 01/2017
2	Neutropenia 01/2021 - 12/2019
2	Residual Neoplasm 12/2020 - 01/2019
2	Triple Negative Breast Neoplasms 01/2019 - 07/2012
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2022
1	Lymphatic Metastasis 04/2022
1	Amyloid Plaque 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Adenocarcinoma 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2021
1	Fatigue 12/2021
1	Hypopituitarism (Sheehan's Syndrome) 12/2021
1	Hypothyroidism 12/2021
1	Cholangiocarcinoma 10/2021
1	Exanthema (Rash) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Anemia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Necrosis 12/2020

Drug/Important Bio-Agent (IBA)

14	Circulating Tumor DNAIBA 04/2022 - 11/2018
9	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2018
7	Immune Checkpoint InhibitorsIBA 09/2022 - 11/2018
6	pembrolizumabIBA 01/2022 - 01/2020
6	Trastuzumab (Herceptin)FDA Link 01/2022 - 12/2010
5	human ERBB2 proteinIBA 01/2022 - 11/2014
5	NivolumabIBA 01/2022 - 01/2019
4	Monoclonal AntibodiesIBA 06/2021 - 01/2019
4	Irinotecan (Camptosar)FDA LinkGeneric 06/2021 - 01/2020
4	Hormones (Hormone)IBA 01/2018 - 01/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 11/2018
3	lenvatinibIBA 01/2022 - 01/2020
3	trifluridine tipiracil drug combinationIBA 07/2021 - 12/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2021 - 02/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 12/2010
2	trastuzumab deruxtecanIBA 06/2022 - 01/2021
2	regorafenibIBA 01/2022 - 01/2021
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2018
2	ParaffinIBA 01/2022 - 01/2018
2	pertuzumabIBA 01/2022 - 11/2021
2	Tumor Biomarkers (Tumor Markers)IBA 10/2021 - 07/2021
2	Capecitabine (Xeloda)FDA Link 07/2021 - 02/2019
2	Cell-Free Nucleic AcidsIBA 03/2021 - 12/2019
2	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2019
2	Estrogen ReceptorsIBA 01/2021 - 11/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2020
2	Taxoids (Taxanes)IBA 01/2020 - 09/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2020
2	AnthracyclinesIBA 09/2017 - 03/2012
2	Aromatase InhibitorsIBA 11/2016 - 03/2011
1	Notch ReceptorsIBA 10/2022
1	Pharmaceutical PreparationsIBA 06/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	CateninsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	AntibodiesIBA 01/2022
1	hydroxide ionIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2021
1	Docetaxel (Taxotere)FDA Link 12/2021
1	Blood Glucose (Blood Sugar)IBA 12/2021
1	Thyroxine (Levothyroxine)FDA LinkGeneric 12/2021
1	Small Cytoplasmic RNAIBA 11/2021
1	Programmed Cell Death 1 ReceptorIBA 10/2021
1	Panitumumab (Vectibix)FDA Link 06/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	DeoxyuridineIBA 01/2021
1	dUTP pyrophosphataseIBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	TAS-114IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2020

Therapy/Procedure

28	Therapeutics 01/2022 - 01/2003
15	Drug Therapy (Chemotherapy) 10/2022 - 12/2010
8	Precision Medicine 01/2022 - 09/2018
5	Adjuvant Chemotherapy 12/2021 - 09/2017
3	Immunotherapy 01/2022 - 01/2019
3	Hepatectomy 12/2021 - 05/2002
2	Neoadjuvant Therapy 01/2022 - 01/2019
2	Molecular Targeted Therapy 01/2022 - 01/2022
2	Gastrectomy 12/2021 - 02/2019
2	Genomic Medicine 02/2021 - 09/2018
1	Lymph Node Excision (Lymph Node Dissection) 04/2022
1	Aftercare (After-Treatment) 04/2022
1	Transplantation 01/2021
1	Combination Drug Therapy (Combination Chemotherapy) 01/2020
1	Radiotherapy 01/2020